Joint Pain Injections Market - Snapshot

The global joint pain injections market is expected to reach a value of above US$ 6 Bn by the end of 2026, expanding at a high single digit CAGR during the forecast period. Increase in prevalence and incidence rates of joint disorders, high unmet needs in patients with joint pain, increased geriatric population, and raised acceptance for comparatively newer treatment options in developing countries are expected to boost the joint pain injections market during the forecast period. According to an article published by WHO, musculoskeletal conditions consists of over 150 diseases and syndromes, which are usually progressive and associated with pain. The conditions with greatest impact on society include rheumatoid arthritis, osteoarthritis, spinal disorders, and severe limb trauma. 

global joint pain injections market

The global joint pain injections market has been segmented based on injections type, joint type, end-user, and region. In terms of injection type, the global market has been classified into corticosteroid injections, hyaluronic acid injections, and others. The hyaluronic acid injections segment dominates the joint pain injections market, in terms of value. Increasing acceptance of hyaluronic acid injections as an alternative to knee surgery is likely to drive the segment. The corticosteroids injections segment is also expected to expand at a significant CAGR during forecast period. This is primarily attributed to the frequent use of corticosteroid injections for joint pain relief in Asia Pacific and Middle East & Africa. According to an article published by NCBI, for evaluating effectiveness of corticosteroid injections, intra-articular corticosteroid injections are more effective in pain relief in the short-term. 

In terms of joint type, the global market has been classified into knee & ankle, hip joint, shoulder & elbow, facet joints of the spine, and others. The knee & ankle segment dominates the joint pain injections market, in terms of value. This is primarily attributed to the increased prevalence and incidences of knee related disorders across the globe. The shoulder & elbow segment is expected to expand at a significant CAGR during forecast period. The expansion is attributed to the wide occurrence of shoulder pain owing to an increased utilization of gadgets such as mobiles, PCs and laptops among the general population. 

In terms of distribution channel, the joint pain injections market has been segregated into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held a major share of the market, followed by the retail pharmacies segment in 2017. The hospital pharmacies segment is expected to maintain its market share during the forecast period, due to increased preference for hospitals for joint pain treatment requiring skilled workforce for parenteral administration. The retail pharmacies segment is projected to expand at a considerable CAGR during the forecast period. The high growth rate of this segment is due to high preference for this channel of distribution in Latin America and Middle East & Africa. 

In terms of region, the joint pain injections market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global joint pain injections market, owing to the high acceptance of viscosupplementation in the U.S., increased prevalence of joint related disorders, technological advancements, increase in geriatric population, and high prevalence of obesity and healthcare spending in the region. The market in Asia Pacific is anticipated expand at a considerably high CAGR during the forecast period, owing to the increased awareness about joint pain in developing countries, such as India, rise in the geriatric population, and high acceptance of viscosupplementation in Japan. 

Major players operating in the joint pain injections market include Allergan Plc., Pfizer Inc., Sanofi, Anika Therapeutics, Inc., Ferring B.V., Bioventus, Flexion Therapeutics, Inc., Zimmer Biomet Holdings, Inc., SEIKAGAKU CORPORATION, and Chugai Pharmaceutical Co., Ltd. Key players are expanding their product portfolios through mergers & acquisitions and partnerships & collaborations with leading pharmaceutical companies, which is expected to increase product availability, and thereby boost the market.

Joint Pain Injections Market: Overview

This report analyzes the current and future scenario of the global joint pain injections market for the period 2018 to 2026. Rise in geriatric population, increased prevalence of joint disorders, and high unmet medical needs are likely to be major drivers of the global joint pain injections market during the forecast period. 

The joint pain injections market report comprises an elaborate executive summary, including a snapshot that provides information on various segments of the market. It also provides information and data analysis of the global market with respect to segments based on injections type, joint, distribution channel, and region. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. Additionally, the section comprises competitive matrix and profiles of key market players, along with business overview, to project the competitive landscape of the market. The section also provides market attractiveness analysis based on region and market share analysis in terms of key players, thereby presenting a thorough analysis of the overall competitive scenario in the joint pain injections market. 

Joint Pain Injections Market: Key Segments

Based on injection type, the global joint pain injections market has been segmented into corticosteroid injections, hyaluronic acid injections, and others. In terms of joint type, the global joint pain injections market has been divided into knee & ankle, hip joint, shoulder & elbow, facet joints of the spine, and others. Based on distribution channel, the market has been segregated into hospital pharmacies, retail pharmacies, and online pharmacies. The market size and forecast for each of these segments have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year. 

Joint Pain Injections Market: Regional Outlook

In terms of region, the global joint pain injections market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). Market size and forecast for each of these regions and the mentioned countries have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions. 

Companies Mentioned in the Report

The report also profiles major players operating in the global joint pain injections market based on various attributes, such as company overview, financial overview, product portfolio, business strategies, and recent developments. The players covered in the report include Allergan Plc., Pfizer Inc., Sanofi, Anika Therapeutics, Inc., Ferring B.V., Bioventus, Flexion Therapeutics, Inc., Zimmer Biomet Holdings, Inc., SEIKAGAKU CORPORATION, and Chugai Pharmaceutical Co., Ltd. The global joint pain injections market has been segmented as below:

  • Joint Pain Injections Market, by Injection Type
    • Corticosteroid Injections
    • Hyaluronic Acid Injections
    • Others
       
  • Joint Pain Injections Market, by Joint Type
    • Knee & Ankle
    • Hip Joint
    • Shoulder & Elbow
    • Facet Joints of the Spine
    • Others
       
  • Joint Pain Injections Market, by End-user
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
       
  • Joint Pain Injections Market, by Region
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • India
      • China
      • Japan
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • South Africa
      • GCC Countries
      • Rest of Middle East & Africa
.